New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 18, 2018 - AstraZeneca announced the FDA approval of Lokelma (sodium zirconium cyclosilicate), for the treatment of hyperkalemia in adults.
Download PDF
Return to publications
